Integra LifeSciencesIART
那斯達克 · USD
12.31
-0.83
(-6.32%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Integra LifeSciencesIART
12.31
-0.83
(-6.32%)
財務數據
損益表
- 3.98
- 3.81
- 3.81
- 3.82
- 3.97
- 3.69
- 4.18
- 3.81
- 4.43
- 3.83
- 3.33
- -4.32
- 0.11
- 0.30
- 3.82
- -7.09
- 13.37
- -8.93
- 16.23
- -13.55
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 382,653 | 442,646 | 380,834 | 418,175 | 368,872 | 397,039 | 382,421 | 381,267 | 380,846 | 398,022 |
營業成本 | 188,221 | 193,574 | 180,596 | 192,258 | 162,038 | 170,546 | 164,076 | 174,241 | 147,975 | 147,937 |
營業毛利 | 194,432 | 249,072 | 200,238 | 225,917 | 206,834 | 226,493 | 218,345 | 207,026 | 232,871 | 250,085 |
營業費用 | 209,929 | 213,445 | 208,389 | 228,946 | 202,870 | 190,446 | 191,752 | 194,522 | 196,489 | 182,245 |
研發費用 | 24,728 | 31,210 | 27,435 | 29,767 | 26,965 | 24,284 | 26,596 | 26,588 | 26,724 | 26,783 |
推銷及管理費用 | 181,497 | 178,520 | 177,193 | 195,472 | 165,798 | 163,128 | 161,948 | 164,908 | 166,657 | 151,919 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 3,704 | 3,715 | 3,761 | 3,707 | 10,107 | 3,034 | 3,208 | 3,026 | 3,108 | 3,543 |
營業利益 | -15,497 | 35,627 | -8,151 | -3,029 | 3,964 | 36,047 | 26,593 | 12,504 | 36,382 | 67,840 |
其他收入及費用 | 4,276 | 5,898 | 7,161 | 6,495 | 4,430 | 6,562 | 5,078 | 3,784 | 5,496 | 9,262 |
利息費用 | 18,815 | 18,984 | 19,373 | 18,651 | 13,624 | 13,751 | 13,062 | 12,464 | 12,100 | 12,894 |
稅前純益 | -30,036 | 22,541 | -20,363 | -15,185 | -5,230 | 28,858 | 18,609 | 3,824 | 29,778 | 64,208 |
所得稅 | -4,743 | 3,106 | -9,667 | -2,783 | -1,949 | 9,024 | -888 | -360 | 5,552 | 11,262 |
稅後純益 | -25,293 | 19,435 | -10,696 | -12,402 | -3,281 | 19,834 | 19,497 | 4,184 | 24,226 | 52,946 |
基本每股稅後盈餘(元) | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 | 0.25 | 0.25 | 0.05 | 0.30 | 0.63 |
稀釋每股稅後盈餘(元) | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 | 0.25 | 0.24 | 0.06 | 0.29 | 0.63 |
基本平均股數(千股) | 76463.00 | 77164.00 | 77134.00 | 77583.00 | 78749.00 | 78169.00 | 79112.00 | 81354.00 | 81895.00 | 84041.00 |
稀釋平均股數(千股) | 76463.00 | 77164.00 | 77134.00 | 77583.00 | 78749.00 | 78169.00 | 79811.00 | 81354.00 | 82322.00 | 84041.00 |
還原基本每股稅後盈餘(元) | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 | 0.25 | 0.25 | 0.05 | 0.30 | 0.63 |
還原稀釋每股稅後盈餘(元) | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 | 0.25 | 0.24 | 0.06 | 0.29 | 0.63 |
還原基本平均股數(千股) | 76,463 | 77,164 | 77,134 | 77,583 | 78,749 | 78,169 | 79,112 | 81,354 | 81,895 | 84,041 |
還原稀釋平均股數(千股) | 76,463 | 77,164 | 77,134 | 77,583 | 78,749 | 78,169 | 79,811 | 81,354 | 82,322 | 84,041 |
EBITDA(千元) | 27,352 | 80,514 | 36,306 | 41,703 | 40,358 | 75,027 | 63,646 | 48,538 | 74,911 | 108,301 |